Global Thrombectomy Devices Market was valued at $982 million in 2016, and is expected to reach $1,389 million by 2022, supported by a CAGR of 5.9% during the forecast period 2016 - 2022.

Portland, OR -- (SBWire) -- 03/01/2018 --hrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries.These are carefully designed to minimize damage to the vessel wall during a procedure, with the minimum blood loss. They are available in different sizes and diameters, and depending on the affected area, the required catheter is chosen. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

The report covers the analysis of global thrombectomy devices market based on five categoriestechnology, type, utility, diseases, and geography. Based on the technology used, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. Based on type, the market is divided into two segmentsadvanced devices and manual devices.

Get the PDF of Thrombectomy Devices industry insights @ https://www.alliedmarketresearch.com/request-sample/1608

Key players have adopted product launch and mergers & acquisitions as their key development strategies. For instance, on September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Also, market leader Boston Scientific received FDA approval and CE mark for its thrombectomy product line called AngioJet ZelanteDVT Thrombectomy Catheter on November 2015. This has helped Boston Scientific to continue to be the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.

The key players profiled in this report include Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation, AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, and Vascular Solutions, Inc.

Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1608

THROMBECTOMY DEVICES MARKET KEY BENEFITS FOR STAKEHOLDERS

- The Global thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
- The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
- The market estimations in this report are based on high-end analysis of the key developments for 2014?2022.
- Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
- In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.

THROMBECTOMY DEVICES MARKET KEY SEGMENTS

The Global thrombectomy devices market segmentation is illustrated as follows:

By Technology

- Mechanical Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Rheolytic Thrombectomy Devices

By Type

- Automated Devices
- Manual Devices

By Utility

- Reusable Devices
- Disposable Devices